Clinical trial
"Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer
NCT00338481 · Sankt Lukas Hospice, Other · Completed
Key facts
| NCT number | NCT00338481 |
|---|---|
| Title | "Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer |
| Official title | "Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Terminal Patients With Primary Lung Cancer or Lung metastases-a Pilot Study |
| Lead sponsor | Sankt Lukas Hospice, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dyspnea, Lung Neoplasms |
| Intervention type | Drug |
| Interventions | Morphine p.o., Morphine s.c. |
| Enrollment | 20 |
| Start date | Apr 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Jun 20, 2006 |
| Last update posted | Jul 27, 2011 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: